Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer

NCT01481259 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

BIOLOGICAL: Autologous cytokine-induced killer cell
OTHER: Pemetrexed

Sponsor

People's Hospital of Guangxi Zhuang Autonomous Region